Zobrazeno 1 - 10
of 7 294
pro vyhledávání: '"C Cho"'
Autor:
M De-Lima, P Kebriaei, F Lanza, C Cho, G Popradi, M Kaur, M Zhang, F Zhang, E Vandendries, K Asomaning, S Dorman, M Stelljes, DI Marks, A Cury, W Saber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S256-S257 (2023)
Objectives: Inotuzumab ozogamicin (InO), a CD22-directed antibody-drug conjugate indicated for relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (ALL), is associated with hepatotoxicity and hepatic veno-occlusive disease/sinusoi
Externí odkaz:
https://doaj.org/article/3cdf7c6e5423497684e702bceb898c51
Publikováno v:
Environmental Research Letters, Vol 10, Iss 2, p 024008 (2015)
Autumn precipitation over Central Vietnam is associated with an increase in the occurrence of tropical cyclones that lead to frequent flooding and pose a significant threat to lives and property. The present analyses reveal a pronounced decadal oscil
Externí odkaz:
https://doaj.org/article/20e27f2e8ecd45109c8b58dce9a4f683
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Asgharzadeh, Fereshteh, Moradi Binabaj, Maryam, Fanoudi, Sahar, C. Cho, William, Yang, Yu-jeong, Azarian, Maryam, Shafiee Ardestani, Mehdi, Nasiri, Nasim, Ramezani Farani, Marzieh, Huh, Yun Suk
Publikováno v:
Advanced Pharmaceutical Bulletin; 2024, Vol. 14 Issue 3, p513-523, 11p
Autor:
Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein, Patrick Y. Wen, Sascha Dietrich, Maja J. A. de Jonge, Jean-Yves Blay, Antoine Italiano, Kan Yonemori, Daniel C. Cho, Filip Y. F. L. de Vos, Philippe Moreau, Elena Elez Fernandez, Jan H. M. Schellens, Christoph C. Zielinski, Suman Redhu, Aislyn Boran, Vanessa Q. Passos, Palanichamy Ilankumaran, Yung-Jue Bang
Publikováno v:
Nature medicine, vol 29, iss 5
Scientia
Nature Medicine, 29(5), 1103-1112. Nature Publishing Group
Scientia
Nature Medicine, 29(5), 1103-1112. Nature Publishing Group
BRAFV600E alterations are prevalent across multiple tumors. Here we present final efficacy and safety results of a phase 2 basket trial of dabrafenib (BRAF kinase inhibitor) plus trametinib (MEK inhibitor) in eight cohorts of patients with BRAFV600E-
Autor:
Sikai, Wu, Zimin, Wang, Jiajing, Sun, Han, Wu, Zixian, Jin, Sijia, Ren, Bingyu, Hu, William C, Cho, Chengchu, Zhu, Tianxiang, Chen, Jianfei, Shen
Publikováno v:
Annals of Surgical Oncology. 30:1522-1529
According to the JCOG0802 study, there were many non-cancer-related deaths in the lobectomy group. Meanwhile, the median age of the enrolled patients in the JCOG0802 study was 67 years old. Whether this difference in perioperative outcomes and surviv
Publikováno v:
Anesthesiology Clinics. 40:605-625
Patient blood management (PBM) is an evidence-based, multidisciplinary approach aimed at appropriately allocating blood products to patients requiring transfusion while simultaneously minimizing inappropriate transfusions. The 3 pillars of patient bl
Publikováno v:
Journal of Rehabilitation Welfare Engineering & Assistive Technology. 16:204-209
Publikováno v:
Human Cell. 36:62-75
Mesenchymal stem/stromal cells (MSCs) are multipotent cells with immunomodulatory effects that have been attempted as a possible treatment for neurologic disorders. Since currently available drugs for neurologic disorders are limited, special attenti
Autor:
Arlene O. Siefker-Radtke, Daniel C. Cho, Adi Diab, Mario Sznol, Mehmet A. Bilen, Arjun V. Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L. Currie, Mary A. Tagliaferri, Jonathan Zalevsky, Michael E. Hurwitz, Nizar M. Tannir
Publikováno v:
European Urology. 82:365-373
Despite recent changes in the treatment landscape, there remains an unmet need for effective, tolerable, chemotherapy-free treatments for patients with advanced/metastatic urothelial carcinoma (mUC), especially cisplatin-ineligible patients.To evalua